HUM vs IRD
Humana Inc (HUM) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IRD currently screens at market cap $35.7M.
Not investment advice. Open the HUM and IRD stock pages for the full models.
Not investment advice.